ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 142 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $293,604 | -91.3% | 451,698 | -77.0% | 0.00% | -85.7% |
Q3 2022 | $3,373,000 | +334.1% | 1,961,127 | +213.0% | 0.01% | +250.0% |
Q2 2022 | $777,000 | +447.2% | 626,531 | +379.4% | 0.00% | – |
Q4 2021 | $142,000 | -85.0% | 130,700 | -74.8% | 0.00% | -100.0% |
Q3 2021 | $944,000 | +667.5% | 518,868 | +964.1% | 0.00% | +300.0% |
Q4 2020 | $123,000 | -7.5% | 48,763 | -7.8% | 0.00% | 0.0% |
Q3 2020 | $133,000 | -61.1% | 52,881 | -49.3% | 0.00% | -50.0% |
Q2 2020 | $342,000 | -39.6% | 104,335 | -29.1% | 0.00% | -33.3% |
Q1 2019 | $566,000 | -21.3% | 147,240 | -61.7% | 0.00% | -57.1% |
Q4 2018 | $719,000 | +212.6% | 384,016 | +435.0% | 0.01% | +600.0% |
Q3 2018 | $230,000 | – | 71,782 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,642,959 | $25,186,000 | 3.76% |
MSD Partners, L.P. | 15,151,516 | $26,061,000 | 2.11% |
MSD Partners, L.P. | 7,575,758 | $13,030,000 | 1.05% |
MAGNOLIA CAPITAL ADVISORS LLC | 418,569 | $720,000 | 0.61% |
STEEL GROVE CAPITAL ADVISORS, LLC | 1,080,000 | $1,858,000 | 0.33% |
EAM Investors, LLC | 454,625 | $782,000 | 0.17% |
Allred Capital Management, LLC | 158,000 | $271,000 | 0.17% |
Boxer Capital, LLC | 1,500,000 | $2,580,000 | 0.14% |
GSA CAPITAL PARTNERS LLP | 608,037 | $1,046,000 | 0.14% |
CHIRON CAPITAL MANAGEMENT, LLC | 116,860 | $201,000 | 0.14% |